Biovance Capital works closely with entrepreneurs to build leading companies with transformative treatments for patients in need.

Please, only send us your project if it meets the following criteria:


We only support early-stage companies with a focus on Portugal, Spain, and Italy.


We require robust results in appropriate preclinical models and patentable assets before investing.


Profound technical expertise is essential, preferably coupled with business/commercial experience. Team needs to be coachable, fast-paced and have a sense of urgency.


Large target market with a clear regulatory pathway for approval, with favorable reimbursement and pricing policies.

Exit Potential

Sectors with high VC/M&A/IPO activity with examples of previous profitable exits and several possible acquirers.